Acute paralysis following recreational MDMA (Ecstasy) use

被引：5
|
作者：
Goldstein, Lee H.
Mordish, Yair
Abu-Kishak, Ibrahim
Toledano, Michal
Berkovitch, Matitiahu [1 ]
机构：
[1] Tel Aviv Univ, Clin Pharmacol & Toxicol Unit, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel
[2] Tel Aviv Univ, Div Pediat, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel
[3] Tel Aviv Univ, Pediat Intens Care Unit, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel
[4] Assaf Harofeh Med Ctr, Dept Pharm, IL-70300 Zerifin, Israel
来源：
CLINICAL TOXICOLOGY | 2006年 / 44卷 / 03期
关键词：
ecstasy; methylenedioxymethamphetamine; spinal cord; quadriplegia; respiratory insufficiency; adolescent; renal failure;
D O I：
10.1080/15563650600584600
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a hallucinogenic compound structurally related to amphetamine. Ecstasy's severe neurological toxicity includes seizures, subarachnoidal hemorrhage, cerebral infarction, intracranial bleeding and cerebral venous thrombosis. We describe the first case of spinal cord damage presenting as acute quadriplegia and respiratory insufficiency in a healthy adolescent following Ecstasy recreational usage.
引用
收藏
页码：339 / 341
页数：3
相关论文
共 50 条
  • [31] Chronic MDMA (ecstasy) use, cognition and mood
    K. McCardle
    S. Luebbers
    J. D. Carter
    R. J. Croft
    C. Stough
    Psychopharmacology, 2004, 173 : 434 - 439
  • [32] The neuropsychology of ecstasy (MDMA) use: A quantitative review
    Zakzanis, Konstantine K.
    Campbell, Zachariah
    Jovanovski, Diana
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (07) : 427 - 435
  • [33] Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects
    Davison, D
    Parrott, AC
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (03) : 221 - 226
  • [34] A subcultural study of recreational ecstasy use
    Gourley, M
    JOURNAL OF SOCIOLOGY, 2004, 40 (01): : 59 - 73
  • [35] Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users
    Parrott, AC
    Buchanan, T
    Scholey, AB
    Heffernan, T
    Ling, J
    Rodgers, J
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (06) : 309 - 312
  • [36] Ecstasy (MDMA), amphetamine, and LSD: Comparative mood profiles in recreational polydrug users
    Parrott, AC
    Stuart, M
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (05) : 501 - 504
  • [37] Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users
    A. C. Parrott
    T. Buchanan
    T. M. Heffernan
    A. Scholey
    J. Ling
    J. Rodgers
    Psychopharmacology, 2003, 167 : 449 - 450
  • [38] Pneumomediastinum as a complication of an ecstasy recreational use.
    Le Floch, AS
    Lapostolle, F
    Danhiez, F
    Adnet, F
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2002, 21 (01): : 35 - 37
  • [39] Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy
    Singer, Lynn T.
    Moore, Derek G.
    Fulton, Sarah
    Goodwin, Julia
    Turner, John J. D.
    Min, Meeyoung O.
    Parrott, Andrew C.
    NEUROTOXICOLOGY AND TERATOLOGY, 2012, 34 (03) : 303 - 310
  • [40] MDMA and the "Ecstasy Paradigm"
    Cole, Jon C.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2014, 46 (01) : 44 - 56
12345